MYLERAN K2A (Myleran 2 MG)
Generic Name: busulfan
Pill imprint MYLERAN K2A has been identified as Myleran 2 MG.
Myleran is used in the treatment of chronic myelogenous leukemia; thrombocythemia; bone marrow transplantation and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Myleran 2 MG is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLERAN K2A (Myleran 2 MG)
Myleran
- Generic Name:
- busulfan
- Imprint:
-
MYLERAN K2A
- Strength:
- 2 MG
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Alkylating agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GLAXO SMITH KLINE
- National Drug Code (NDC):
- 00173-0713
- Inactive Ingredients:
- hypromellose
lactose anhydrous
magnesium stearate
corn starch
triacetin
titanium dioxide
More resources
Myleran is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
